{
    "clinical_study": {
        "@rank": "144474", 
        "arm_group": {
            "arm_group_label": "BGStar", 
            "arm_group_type": "Other", 
            "description": "Comparision"
        }, 
        "brief_summary": {
            "textblock": "Due to continuing technological progress and better understanding of the needs for glucose\n      monitoring, the performance requirements of blood glucose meters, primarily regarding their\n      accuracy, are constantly debated and keep evolving as a consequence. Recently a discussion\n      was initiated by the Food and Drug Administration (FDA) to improve the accuracy of BG meters\n      in the point-of-care testing setting by asking for fulfilment of higher requirements."
        }, 
        "brief_title": "A Trial Investigating the Accuracy and Precision of the BGStar\u00ae and iBGStar\u00ae Blood Glucose Meter in Subjects With Type 1 Diabetes", 
        "condition": "Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Signed and dated informed consent obtained before any trial-related activities.\n             Trial-related activities are any procedures that are carried out as part of the\n             trial, including activities to determine suitability for the trial.\n\n          2. Male or female subjects aged 18-74 years (both inclusive).\n\n          3. Type 1 diabetes mellitus (as diagnosed clinically) \u2265 12 months.\n\n          4. Body mass index 18.0-28.0 kg/m2 (both inclusive).\n\n          5. HbA1c \u2264 9.0 % by local laboratory analysis.\n\n        Exclusion Criteria:\n\n          1. Known or suspected hypersensitivity to lancet fingerpricks / needle injections.\n\n          2. Previous participation in this trial. Participation is defined as having performed at\n             least one BG meter measurement as part of the study.\n\n          3. Receipt of any investigational medicinal product within 30 days before randomisation\n             in this trial.\n\n          4. Formation of callus on the fingertips or any other skin condition that may hamper\n             fingerprick blood sampling and/or insufficient capillary blood volume sampling (< 50\n             \u03bcL) during test fingerprick(s).\n\n          5. Haemoglobin < 8.0 mmol/L (male) or < 6.4 mmol/L (female), total leukocyte count < 3.0\n             x 109/L, thrombocytes <100 x 109/L, serum creatinine levels \u2265 126 \u03bcmol/L (male) or \u2265\n             111 \u03bcmol/L (female), bilirubin > 3x the upper limit of normal (ULN), and alanine\n             aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP)\n             and gamma-glutamyl transferase (\u03b3-GT) > 2 x ULN.\n\n          6. Suffer from or history of a life threatening disease (i.e. cancer except basal cell\n             skin cancer or squamous cell skin cancer), or any clinically significant respiratory,\n             metabolic, renal, hepatic, gastrointestinal, endocrinological (with the exception of\n             diabetes mellitus and euthyroid struma), haematological, dermatological, venereal, -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "74 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01730885", 
            "org_study_id": "BGStar"
        }, 
        "intervention": {
            "arm_group_label": "BGStar", 
            "intervention_name": "Comparison of different Blood Glucose Meters", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Neuss", 
                    "country": "Germany", 
                    "state": "NRW", 
                    "zip": "41460"
                }, 
                "name": "Profil Institut f\u00fcr Stoffwechselforschung GmbH"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Mean absolute relative deviation (MARD) from paired reference values of BGStar\u00ae, iBGStar\u00ae and comparator BG meter measurements at stable hypoglycaemic, euglycaemic and hyperglycaemic levels and overal", 
            "safety_issue": "No", 
            "time_frame": "6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01730885"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
        "sponsors": {
            "collaborator": {
                "agency": "Sanofi", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Profil Institut f\u00fcr Stoffwechselforschung GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Factorial Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}